Confluence Wealth Services Inc. Trims Stock Position in UnitedHealth Group Incorporated $UNH

Confluence Wealth Services Inc. trimmed its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 5.1% during the 2nd quarter, Holdings Channel reports. The fund owned 7,101 shares of the healthcare conglomerate’s stock after selling 379 shares during the quarter. Confluence Wealth Services Inc.’s holdings in UnitedHealth Group were worth $2,215,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also recently made changes to their positions in the company. Brighton Jones LLC grew its position in shares of UnitedHealth Group by 176.2% during the 4th quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock valued at $22,384,000 after acquiring an additional 28,231 shares during the period. Revolve Wealth Partners LLC increased its position in shares of UnitedHealth Group by 137.1% in the fourth quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock valued at $2,033,000 after buying an additional 2,324 shares in the last quarter. Patriot Financial Group Insurance Agency LLC lifted its position in shares of UnitedHealth Group by 6.0% during the 1st quarter. Patriot Financial Group Insurance Agency LLC now owns 3,729 shares of the healthcare conglomerate’s stock valued at $1,953,000 after buying an additional 211 shares in the last quarter. RDA Financial Network lifted its holdings in UnitedHealth Group by 3.4% during the first quarter. RDA Financial Network now owns 9,282 shares of the healthcare conglomerate’s stock valued at $4,861,000 after purchasing an additional 304 shares in the last quarter. Finally, ARS Wealth Advisors Group LLC increased its stake in shares of UnitedHealth Group by 3.6% during the first quarter. ARS Wealth Advisors Group LLC now owns 28,650 shares of the healthcare conglomerate’s stock worth $15,005,000 after purchasing an additional 1,004 shares in the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several equities research analysts have commented on UNH shares. Baird R W lowered UnitedHealth Group from a “hold” rating to a “strong sell” rating in a research note on Thursday, July 31st. JPMorgan Chase & Co. decreased their price objective on UnitedHealth Group from $418.00 to $310.00 and set an “overweight” rating on the stock in a report on Wednesday, August 6th. Cantor Fitzgerald reiterated an “overweight” rating and issued a $440.00 target price on shares of UnitedHealth Group in a research report on Tuesday, August 26th. KeyCorp dropped their price objective on shares of UnitedHealth Group from $400.00 to $350.00 and set an “overweight” rating for the company in a report on Wednesday, July 30th. Finally, Morgan Stanley increased their price target on shares of UnitedHealth Group from $325.00 to $395.00 and gave the company an “overweight” rating in a research note on Friday, September 12th. Sixteen analysts have rated the stock with a Buy rating, six have given a Hold rating and four have issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $358.95.

UnitedHealth Group Trading Up 1.8%

NYSE UNH opened at $360.17 on Monday. The firm has a market cap of $326.20 billion, a PE ratio of 15.61, a P/E/G ratio of 2.34 and a beta of 0.47. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. The firm’s fifty day moving average is $307.84 and its two-hundred day moving average is $353.45. UnitedHealth Group Incorporated has a one year low of $234.60 and a one year high of $630.73.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The firm had revenue of $111.62 billion for the quarter, compared to analysts’ expectations of $111.75 billion. During the same period in the prior year, the company earned $6.80 earnings per share. The company’s revenue for the quarter was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Investors of record on Monday, September 15th were paid a $2.21 dividend. This represents a $8.84 annualized dividend and a yield of 2.5%. The ex-dividend date was Monday, September 15th. UnitedHealth Group’s dividend payout ratio is presently 38.30%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.